Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) appointed Ana I. Stancic Senior Vice President and Chief Financial Officer of the Company. Ana had been Senior Vice President and Chief Financial Officer of M2Gen, a wholly owned for-profit subsidiary of Moffitt Cancer Center, and before that Chief Financial Officer of Aureon Biosciences. Read more in the Business Wire press release.
Recent Comments